(Q37735306)

22 August 2017

1 reference

title

Treatment of latent tuberculosis infection: An update (English)

1 reference

22 August 2017

0 references

1 reference

2

Dick Menzies

1 reference

22 August 2017

Philip Lobue

1

1 reference

22 August 2017

7 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

15

1 reference

22 August 2017

4

1 reference

22 August 2017

603-622

1 reference

When tuberculosis treatment fails. A social behavioral account of patient adherence

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Mycobacterium tuberculosis in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

The epidemiology of tuberculosis in gold miners with silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Tuberculosis in a Cohort of Southeast Asian Refugees: A Five-Year Surveillance Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Isoniazid-associated hepatitis. Report of an outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

Rifampin preventive therapy for tuberculosis in Boston's homeless.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2010.01751.X

10.1111/J.1440-1843.2010.01751.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20409026